Zinc(II) Complexes of Acylpyrazolones Decorated with a Cyclohexyl Group Display Antiproliferative Activity Against Human Breast Cancer Cells
暂无分享,去创建一个
A. Crispini | S. Morelli | C. Pettinari | I. Aiello | F. Marchetti | L. Bartolo | R. Pettinari | C. Nicola | M. Deda | A. Candreva
[1] Yu-hua Fan,et al. Crystal structures and anticancer activities of five novel pyrazolone-enamine transition metal complexes with 4-benzoyl-3-methyl-1-phenyl-2-pyrazolin-5-one , 2018, Journal of Molecular Structure.
[2] R. Scopelliti,et al. Synthesis, characterization and cytotoxicity of arene-ruthenium(ii) complexes with acylpyrazolones functionalized with aromatic groups in the acyl moiety. , 2018, Dalton transactions.
[3] Ž. Bugarčić,et al. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives. , 2017, European journal of medicinal chemistry.
[4] M. Dušek,et al. A detailed study on the interaction of a novel water-soluble glycine bridged zinc(II) Schiff base coordination polymer with BSA: Synthesis, crystal structure, molecular docking and cytotoxicity effect against A549, Jurkat and Raji cell lines , 2017 .
[5] N. Revathi,et al. Biologically Active Cu(II), Co(II), Ni(II) and Zn(II) Complexes of Pyrimidine Derivative Schiff Base: DNA Binding, Antioxidant, Antibacterial and In Vitro Anticancer Studies , 2017, Journal of Fluorescence.
[6] E. Drioli,et al. Microtube array membrane bioreactor promotes neuronal differentiation and orientation , 2017, Biofabrication.
[7] N. Raman,et al. Role of Knoevenagel condensate pyrazolone derivative Schiff base ligated transition metal complexes in biological assay and cytotoxic efficacy , 2017 .
[8] R. Ortega,et al. Zinc and Copper Effects on Stability of Tubulin and Actin Networks in Dendrites and Spines of Hippocampal Neurons. , 2017, ACS chemical neuroscience.
[9] E. Drioli,et al. Neuronal membrane bioreactor as a tool for testing crocin neuroprotective effect in Alzheimer’s disease , 2016 .
[10] R. Scopelliti,et al. Synthesis, Structure, and Anticancer Activity of Arene-Ruthenium(II) Complexes with Acylpyrazolones Bearing Aliphatic Groups in the Acyl Moiety. , 2016, Inorganic chemistry.
[11] Agnieszka Gornowicz,et al. Biological evaluation of dimethylpyridine–platinum complexes with potent antiproliferative activity , 2016, Journal of enzyme inhibition and medicinal chemistry.
[12] A. Linden,et al. Organotin(IV) complexes derived from proteinogenic amino acid: synthesis, structure and evaluation of larvicidal efficacy onAnopheles stephensimosquito larvae , 2016, Applied Organometallic Chemistry.
[13] R. Subramaniam,et al. New anticancer zinc(II) complexes comprising thiosemicarbazones of saturated ring: structure, DNA/protein binding, DNA cleavage, topoisomerase‐1 inhibition and anti‐proliferation studies , 2016 .
[14] S. Tabassum,et al. Current and future potential of metallo drugs: Revisiting DNA-binding of metal containing molecules and their diverse mechanism of action , 2016 .
[15] R. Alizadeh-Navaei,et al. Cytotoxic and apoptogenic effect of hypericin, the bioactive component of Hypericum perforatum on the MCF-7 human breast cancer cell line , 2016, Cancer Cell International.
[16] You-nian Liu,et al. Cytotoxicity, DNA binding and cell apoptosis induction of a zinc(II) complex of HBrQ , 2015 .
[17] C. Pettinari,et al. Recent advances in acylpyrazolone metal complexes and their potential applications , 2015 .
[18] D. Maria,et al. Synthesis, characterization and biological evaluation of Rutin-zinc(II) flavonoid -metal complex. , 2015, Chemico-biological interactions.
[19] C. Pettinari,et al. Dinuclear (η6-arene) ruthenium(II) acylpyrazolone complexes: Synthesis, characterization and cytotoxicity , 2015 .
[20] A. Garufi,et al. Zn(II)-curc targets p53 in thyroid cancer cells , 2015, International journal of oncology.
[21] J. Holopainen,et al. Osteogenic and osteoclastogenic differentiation of co-cultured cells in polylactic acid-nanohydroxyapatite fiber scaffolds. , 2015, Journal of biotechnology.
[22] A. Crispini,et al. Zn(ii) and Cu(ii) complexes containing bioactive O,O-chelated ligands: Homoleptic and heteroleptic metal-based biomolecules. , 2015, Dalton transactions.
[23] E. Drioli,et al. Neuronal growth and differentiation on biodegradable membranes , 2015, Journal of tissue engineering and regenerative medicine.
[24] M. Mozzicafreddo,et al. Arene-ruthenium(II) acylpyrazolonato complexes: apoptosis-promoting effects on human cancer cells. , 2014, Journal of medicinal chemistry.
[25] A. Garufi,et al. Degradation of mutant p53H175 protein by Zn(II) through autophagy , 2014, Cell Death and Disease.
[26] L. Ricci-Vitiani,et al. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo , 2014, Cell Death and Disease.
[27] S. Manna,et al. Synthesis and characterization of some water soluble Zn(II) complexes with (E)-N-(pyridin-2-ylmethylene)arylamines that regulate tumour cell death by interacting with DNA. , 2014, Dalton transactions.
[28] R. Jadeja,et al. Zn(II) coordination compounds derived from 4-acyl pyrazolones and 1,10 phenanthroline: Syntheses, crystal structures, spectral analysis and DNA binding studies , 2013 .
[29] C. Leonetti,et al. A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells , 2013, Journal of experimental & clinical cancer research : CR.
[30] A. Crispini,et al. Improving the bioactivity of Zn(II)-curcumin based complexes. , 2013, Dalton transactions.
[31] K. Moelling,et al. Photodynamic agents with anti-metastatic activities. , 2013, ACS chemical biology.
[32] A. Crispini,et al. Non-classical anticancer agents: on the way to water soluble zinc(II) heteroleptic complexes. , 2013, Dalton transactions.
[33] Wentao Xu,et al. Zinc protects HepG2 cells against the oxidative damage and DNA damage induced by ochratoxin A. , 2013, Toxicology and applied pharmacology.
[34] Ping Zhan,et al. XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis , 2013, Journal of experimental & clinical cancer research : CR.
[35] Mohd Afzal,et al. Synthesis and characterization of copper(II) and zinc(II)-based potential chemotherapeutic compounds: their biological evaluation viz. DNA binding profile, cleavage and antimicrobial activity. , 2012, European journal of medicinal chemistry.
[36] Elisabeta I. Szerb,et al. “Green light” for Zn(II) mesogens , 2012 .
[37] J. Muthumary,et al. A series of oxyimine-based macrocyclic dinuclear zinc(II) complexes enhances phosphate ester hydrolysis, DNA binding, DNA hydrolysis, and lactate dehydrogenase inhibition and induces apoptosis. , 2012, Inorganic chemistry.
[38] I. D'Agnano,et al. DNA binding and cytotoxicity of fluorescent curcumin-based Zn(II) complexes , 2012 .
[39] E. Alessio. Bioinorganic Medicinal Chemistry: ALESSIO:BIO. INORG. CHEM. O-BK , 2011 .
[40] J. Ellman,et al. Design and synthesis of nonpeptidic, small molecule inhibitors for the Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. , 2010, Organic & biomolecular chemistry.
[41] S. Tabassum,et al. Synthesis, structural and spectroscopic characterization and biomimetic properties of new copper, manganese, zinc complexes: identification of possible superoxide-dismutase mimics bearing hydroxyl radical generating/scavenging abilities. , 2010, Journal of inorganic biochemistry.
[42] A. Valentini,et al. Non-classical anticancer agents: synthesis and biological evaluation of zinc(II) heteroleptic complexes. , 2010, Dalton transactions.
[43] T. Stanojković,et al. Zinc(II) complexes of 2-acetyl pyridine 1-(4-fluorophenyl)-piperazinyl thiosemicarbazone: Synthesis, spectroscopic study and crystal structures - potential anticancer drugs. , 2010, Journal of inorganic biochemistry.
[44] B. Keppler,et al. Comparative Solution Equilibrium Study of the Interactions of Copper(II), Iron(II) and Zinc(II) with Triapine (3‐Aminopyridine‐2‐carbaldehyde Thiosemicarbazone) and Related Ligands , 2010 .
[45] B. Ghosh,et al. Inhibitory effect of beta-diketones and their metal complexes on TNF-alpha induced expression of ICAM-1 on human endothelial cells. , 2009, Bioorganic & medicinal chemistry.
[46] R. Jastrząb,et al. Self-assembled synthesis, characterization and antimicrobial activity of zinc(II) salicylaldimine complexes , 2009 .
[47] Hiromu Sakurai,et al. Current state for the development of metallopharmaceutics and anti-diabetic metal complexes. , 2008, Chemical Society reviews.
[48] M. Hiromura,et al. Molecular mechanism of antidiabetic zinc–allixin complexes: regulations of glucose utilization and lipid metabolism , 2008, JBIC Journal of Biological Inorganic Chemistry.
[49] C. Pettinari,et al. Synthesis, Molecular Structure (X-ray and DFT), and Solution Behavior of Titanium 4-Acyl-5-pyrazolonates. Correlations with Related Antitumor β-Diketonato Derivatives , 2007 .
[50] T. Alber,et al. Fragment-based substrate activity screening method for the identification of potent inhibitors of the Mycobacterium tuberculosis phosphatase PtpB. , 2007, Journal of the American Chemical Society.
[51] Z. Chohan,et al. Metal‐based antibacterial and antifungal amino acid derived Schiff bases: their synthesis, characterization and in vitro biological activity , 2007 .
[52] O. Issinger,et al. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1. , 2006, International journal of oncology.
[53] Xiaolian Zhang,et al. Zinc(II) and copper(II) complexes of beta-substituted hydroxylporphyrins as tumor photosensitizers. , 2006, Bioorganic & medicinal chemistry letters.
[54] C. Pettinari,et al. Acylpyrazolone ligands : Synthesis, structures, metal coordination chemistry and applications , 2005 .
[55] A. Gindulyte,et al. (4‐Acyl‐5‐pyrazolonato)titanium Derivatives: Oligomerization, Hydrolysis, Voltammetry, and DFT Study , 2003 .
[56] S. Diez,et al. Synthesis, structure, and antitumor activity of a novel tetranuclear titanium complex. , 2000, Journal of medicinal chemistry.
[57] C. Pettinari,et al. On the interaction of acylpyrazolonates with zinc(II) acceptors: the role of ancillary ligands , 2000 .
[58] R. Macdonald. The role of zinc in growth and cell proliferation. , 2000, The Journal of nutrition.
[59] U. Schilde,et al. Aquabis(3-methyl-4-octanoyl-1-phenyl-5-pyrazolonato-O,O')zinc(II) and Bis(ethanol-O)bis(3-methyl-1-phenyl-4-stearoyl-5-pyrazolonato-O,O')cadmium(II) , 1998 .
[60] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[61] S. M. Taghdisi,et al. Kojic acid and its manganese and zinc complexes as potential radioprotective agents. , 2007, Bioorganic & medicinal chemistry letters.
[62] N. Zaffaroni,et al. Synthesis, spectroscopy (IR, multinuclear NMR, ESI-MS), diffraction, density functional study and in vitro antiproliferative activity of pyrazole-beta-diketone dihalotin(IV) compounds on 5 melanoma cell lines. , 2006, Journal of inorganic biochemistry.